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Abstract 
Background: Adipose‑derived stem cells (ASCs) have been identified as a population of multipotent cells with 
promising applications in tissue engineering and regenerative medicine. ASCs are abundant in fat tissue, which can 
be safely harvested through the minimally invasive procedure of liposuction. However, there exist a variety of dif‑
ferent harvesting methods, with unclear impact on ASC regenerative potential. The aim of this study was thus to 
compare the functionality of ASCs derived from the common technique of suction‑assisted lipoaspiration (SAL) versus 
resection.
Methods: Human adipose tissue was obtained from paired abdominoplasty and SAL samples from three female 
donors, and was processed to isolate the stromal vascular fraction. Fluorescence‑activated cell sorting was used to 
determine ASC yield, and cell viability was assayed. Adipogenic and osteogenic differentiation capacity were assessed 
in vitro using phenotypic staining and quantification of gene expression. Finally, ASCs were applied in an in vivo 
model of tissue repair to evaluate their regenerative potential.
Results: SAL specimens provided significantly fewer ASCs when compared to excised fat tissue, however, with 
equivalent viability. SAL‑derived ASCs demonstrated greater expression of the adipogenic markers FABP‑4 and LPL, 
although this did not result in a difference in adipogenic differentiation. There were no differences detected in osteo‑
genic differentiation capacity as measured by alkaline phosphatase, mineralization or osteogenic gene expression. 
Both SAL‑ and resection‑derived ASCs enhanced significantly cutaneous healing and vascularization in vivo, with no 
significant difference between the two groups.
Conclusion: SAL provides viable ASCs with full capacity for multi‑lineage differentiation and tissue regeneration, and 
is an effective method of obtaining ASCs for cell‑based therapies.
© 2016 Duscher et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Adipose tissue has recently been identified as a promis-
ing source of multipotent cells for use in regenerative 
medicine. Adipose-derived stem cells (ASCs) are cells 
of mesenchymal origin with a capacity to differentiate 
through adipogenic, osteogenic, and chrondrogenic lin-
eages, among others [1, 2]. Notably, in contrast to bone 
marrow-derived mesenchymal stem cells (BM-MSCs), 
ASCs derived from adipose tissue are abundant [3] and 
relatively easily obtainable [1, 2, 4]. Due to their high 
yield in adipose tissue, ASCs additionally have the poten-





*Correspondence:  dominikduscher@me.com; ggurtner@stanford.edu 
1 Hagey Laboratory for Pediatric Regenerative Medicine, Division of Plastic 
Surgery, Department of Surgery, Stanford University School of Medicine, 
Stanford, CA, USA
2 Section of Plastic, Aesthetic and Reconstructive Surgery, Johannes 
Kepler University, Linz, Austria
Full list of author information is available at the end of the article
Page 2 of 11Duscher et al. J Transl Med  (2016) 14:126 
The potential utility of ASCs in tissue engineering and 
cell-based regenerative therapies has been confirmed in a 
variety of pre-clinical and clinical applications. For exam-
ple, pullulan-collagen hydrogel scaffolds seeded with 
ASCs have been demonstrated to increase vascularity 
and improve wound healing [5, 6]. With regard to skeletal 
regenerative potential, implantation of an ASC-seeded 
hydroxyapatite-coated poly (lactic-co-glycolic acid) scaf-
fold into a critical-sized calvarial defect resulted in signif-
icant healing of the defect within 8 weeks [7, 8]. Finally, 
the adipogenic and angiogenic capabilities of ASCs have 
been utilized in the technique of cell-assisted lipotransfer 
(CAL), in which fat grafts are enriched with their native 
ASCs to improve retention and variability [9–12].
However, there exist a variety of different methods to 
obtain adipose tissue in clinical practice, with unclear 
impact on the viability and regenerative potential of 
ASCs. The current standard method for fat harvest for 
regenerative medicine purposes is liposuction. Specifi-
cally, suction-assisted lipoaspiration (SAL) [13], which 
uses manual movement of a small suction cannula to 
mechanically disrupt the adipose tissue, is most widely 
used [14, 15]. Previous work from our laboratory has 
demonstrated that relative to SAL, laser-assisted lipo-
suction (LAL) leads to reduced ASC viability and in vivo 
regenerative potential [16], while ultrasound-assisted 
liposuction (UAL) does not affect ASC yield, prolifera-
tion, differentiation or capacity for tissue regeneration 
[17]. However, it remains to be determined what effects 
SAL itself has on key ASC characteristics. Therefore, the 
aim of this study was to determine the effects of SAL on 
ASC yield, viability, in  vitro adipogenic and osteogenic 
differentiation capabilities, as well as in vivo regenerative 
potential by comparing ASCs derived from SAL lipoaspi-
rates and those from resected adipose tissue.
Methods
Human adipose tissue collection and stromal vascular 
fraction isolation
Human adipose tissue was obtained from three healthy 
female donors after informed consent under approval 
of the Stanford University Institutional Review Board 
(Protocol no. 2188). Both abdominoplasty and suction-
assisted lipoaspiration specimens were collected from 
each patient. Patients were female, 36–54  years of age, 
and had no known comorbidities. SAL was performed at 
a negative pressure of 760 mmHg using a 5 mm rounded, 
blunt cannula.
Lipoaspirate was processed to obtain the stromal vascu-
lar fraction as described previously [2]. Briefly, lipoaspi-
rate was washed with sterile phosphate-buffered saline, 
followed by removal of the oil and blood/saline layers. The 
remaining fat layer was digested with Type II collagenase 
(Sigma-Aldrich; St. Louis, MO) in Medium 199 (Cellgro; 
Manassas, VA, USA) in a 37 °C water bath at 180 rpm for 
30 min. The mixture was centrifuged at 1500g for 20 min 
at 4  °C and the supernatant was discarded. The cellular 
pellet was re-suspended in Dulbecco’s Modified Eagle’s 
Medium (DMEM) (Invitrogen; Carlsbad, CA, USA) with 
10 % fetal bovine serum (FBS), filtered through a 100 µm 
pore size cell strainer (Corning; Corning, NY, USA), cen-
trifuged at 300g for 15 min, and the supernatant was dis-
carded once again. The cell pellet was then re-suspended 
in red cell lysis buffer and centrifuged once more time 
before re-suspending the stromal vascular fraction (SVF) 
in complete medium. Excised abdominoplasty specimens 
were de-epithelialized, mechanically minced into small 
pieces, and then digested and processed in the same man-
ner as the lipoaspirate samples.
Fluorescence‑assisted cell sorting analysis
Our group recently demonstrated significant differences 
in the transcriptional profiles of primary ASCs when 
compared to cultured cells stressing the importance of 
using primary or very early passage cells in in all transla-
tional studies [18]. Therefore we utilized freshly isolated 
SVF and stained it for immediate fluorescence-activated 
cell sorting (FACS) to identify the ASC fraction. ASCs 
were defined by the established surface marker profile 
CD45-/CD31-/CD34+  [16, 19, 20]. Mouse anti-human 
monoclonal antibodies CD31-PE, CD45-PeCy7, and 
CD34-APC (BD Biosciences; San Jose, CA, USA) were 
used and propidium iodide staining was employed to 
exclude dead cells. Analysis was performed using a BD 
FACSAria machine (BD Biosciences).
In vitro viability assay
Freshly extracted ASCs from SAL and excisional fat were 
seeded into a 96-well plate for determination of viability 
by MTT assay (Vybrant MTT Cell Proliferation Assay 
Kit, Invitrogen; Carlsbad, CA, USA).
In vitro osteogenic differentiation
ASCs derived from SAL lipoaspirates and excised adipose 
tissue at passage two were cultured in osteogenic differ-
entiation media (ODM), containing 10 % FBS, 1 % peni-
cillin/streptomycin, 100 μg/mL ascorbic acid, and 10 mM 
β-glycerol 2-phosphate [21]. An alkaline phosphatase 
assay (Sigma-Aldrich) was performed after 7 days in cul-
ture with ODM, and mineralization was assessed using 
Alizarin Red staining at day 14. Alizarin Red staining was 
extracted with 20 % methanol and 10 % acetic acid in dis-
tilled water, and quantified using a spectrophotometer at 
450 nm.
Total RNA was harvested immediately prior to begin-
ning osteogenic stimulation with ODM at day 0, then 
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again at day 7 and day 14 in osteogenic culture, and 
processed using the RNeasy Mini Kit (Qiagen; Hilden, 
Germany). Reverse transcription was performed using 
TaqMan Reverse Transcription Reagents (Invitrogen). An 
ABI Prism 7900HT Sequence Detection System (Applied 
Biosystems; Foster City, CA, USA) was used to perform 
quantitative real-time polymerase chain reaction (qRT-
PCR) with Power SYBR Green PCR Master Mix (Applied 
Biosystems) as the reporter. qRT-PCR analysis was con-
ducted to detect gene expression levels of the early 
osteogenic marker Runt-related transcription factor-2 
(RUNX-2) as well as the late osteogenic marker osteocal-
cin (OCN). Expression levels of RUNX-2 and OCN were 
normalized to beta-actin expression values.
In vitro adipogenic differentiation
Cells from both groups were passaged twice and seeded 
in standard 6-well plates in triplicate at equal density. 
After reaching 70  % confluence, ASCs were cultured in 
adipogenic differentiation medium (ADM), consisting of 
DMEM, 10 % FBS, 1 % penicillin/streptomycin, 10 μg/mL 
insulin, 1  μM dexamethasone, 0.5  mM methylxanthine, 
and 200  μM indomethacin. Lipid accumulation was 
determined using Oil Red O (ORO) staining after 7 days 
in culture with ADM. Staining was imaged using a Leica 
DC300 camera and Leica DM IL inverted contrasting 
microscope at 10×  magnification, then extracted with 
isopropanol, and quantified by absorbance spectropho-
tometry at 520 nm.
Total RNA was harvested at day 0 and day 7 of adi-
pogenic induction culture. Expression levels of the 
adipogenic differentiation markers peroxisome prolif-
erator-activated receptor γ (PPAR-γ), fatty acid bind-
ing protein 4 (FABP4/AP2), and lipoprotein lipase (LPL) 
were determined at two time points during adipogenic 
differentiation. Gene expression values were normalized 
to beta-actin.
Animals
All mice were housed in the Stanford University Veteri-
nary Service Center in accordance with NIH and insti-
tution-approved animal care guidelines. All procedures 
were approved by the Stanford Administrative Panel on 
Laboratory Animal Care.
In vivo excisional wound model
Nude male Crl:CD-1-Foxn1nu mice (Charles River Labo-
ratories, Wilmington, MA, USA http://www.criver.com) 
between 8 and 12 weeks of age were randomized to three 
treatment groups: unseeded hydrogel control or hydrogel 
seeded with human ASC isolated from SAL lipoaspirates 
or resected adipose tissue. Pullulan-collagen hydrogel 
was produced as and seeded as described previously [5, 
22]. Briefly, 2.5 × 105 human ASCs suspended in 15 μL of 
PBS solution were pipetted onto hydrophobic wax paper 
and the hydrogel absorbed the cells actively by capil-
lary, hydrophobic and entropic forces [5]. As previously 
described [23], two 6 mm full thickness wounds were cre-
ated at the dorsum of each mouse. Each wound was held 
open by donut shaped silicone rings sutured on with 6-0 
nylon sutures to prevent wound contraction and allow 
for healing by granulation. Wounds were covered with an 
occlusive dressing (Tegaderm, 3 M, St. Paul, MN, http://
www.3m.com). Photographs were taken on days 0, 3, 5, 
7, 9, 11, 13 and 15 and wound area was measured using 
ImageJ software (National Institute of Health, Bethesda, 
MD, http://www.nih.gov) (n = 8 wounds/group).
Assessment of wound vascularity
To evaluate wound vascularity, immunohistochemical 
staining for the endothelial cell marker CD31 was per-
formed as described previously (n  =  8 wounds/condi-
tion) [22]. Briefly, wounds were harvested upon closure 
and processed for paraffin sectioning. Seven micron 
thick paraffin sections were stained with primary anti-
body (1:100 Rb α CD31, Ab28364, Abcam, Cambridge, 
UK, http://www.abcam.com) overnight at 4  °C, fol-
lowed by secondary antibody staining (1:400 AF547 Gt 
α Rb, Life Technologies, Grand Island, NY, USA http://
www.lifetechnologies.com). Cell nuclei were visualized 
with the nuclear stain DAPI. ImageJ (National Institute 
of Health, Bethesda, MD, USA http://www.nih.gov) was 
used to binarize immunofluorescent images taken with 
the same gain, exposure, and excitation settings as previ-
ously described [22]. Intensity threshold values were set 
automatically and quantification of CD31 staining was 
determined by pixel-positive area per high power field.
Statistical analysis
Data are shown as mean ± SEM. Statistical analyses were 
performed using GraphPad Prism software (GraphPad 
Software, Inc.). Statistical comparisons were made using 
Student’s t-tests and ANOVAs, with Bonferroni correc-
tions for multiple comparisons where appropriate. A 
*p value of < 0.05 was considered statistically significant.
Results
SAL yields a decreased frequency of ASCs
ASC yield was assessed in freshly harvested SVF from 
lipoaspirates and resected adipose tissue to determine 
if SAL impacts ASC frequency. FACS analysis showed 
greater frequency of ASCs in SVF harvested from exci-
sional fat compared to those from SAL (*p  <  0.05) 
(Fig.  1a). The average yield of ASCs in processed SAL 
specimens was 42.4 %, and in processed abdominoplasty 
specimens was 55.8 % (Fig. 1b).
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Fig. 1 ASCs are less frequent in SAL lipoaspirates than in resected adipose tissue but display comparable viability. a Flow cytometric analysis evalu‑
ating the frequency of CD45‑ cells (top row) and ASCs (CD45‑/31‑/34+ cells; bottom row) within the SVF from SAL lipoaspirates and excised adipose 
tissue. b Quantification of CD45‑/31‑/34+ ASCs in SAL and excised adipose tissue derived. c MTT assay demonstrating no significant difference 
regarding cellular viability. n = 3. All data are means ± one SEM. SAL suction‑assisted liposuction
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SAL does not compromise ASC viability
A reduction of ASC yield in SAL lipoaspirates, did not 
result in an impaired ASC viability. An MTT assay was 
performed to assess the impact of SAL on ASC viability 
when compared to excision. Cell viability was not signifi-
cantly different between ASCs harvested by SAL or exci-
sion (p = 0.53) (Fig. 1c).
Osteogenic differentiation potential
In order to determine the osteogenic differentiation 
potential of ASCs isolated from either SAL or excisional 
fat samples, ASCs were cultured in ODM for 14  days. 
There were no significant differences detected in alka-
line phosphatase activity after 7 days in ODM (p = 0.44) 
(Fig.  2a) or in mineralization of the extracellular matrix 
at day 14, as measured by Alizarin Red assay (p = 0.06) 
(Fig.  2b). Similarly, there were no significant differences 
in expression of the osteogenic differentiation markers 
RUNX-2 or OCN between the SAL- and excision-derived 
ASCs, at any time points assessed (Fig. 2c).
Adipogenic differentiation potential
Cells were cultured in ADM for 7 days to determine adi-
pogenic differentiation potential of ASCs derived from 
SAL or excisional fat. Lipid accumulation was confirmed 
by ORO staining after 7  days of culture in ADM, indi-
cating appropriate adipogenic differentiation of ASCs. 
Quantification of Oil Red O staining showed no sig-
nificant differences between the two groups (p  =  0.47) 
(Fig.  3a). Additionally, RNA was harvested prior to 
induction of differentiation at day 0 and again after 7 days 
of culture in ADM to correlate adipogenic marker tran-
script expression levels with observed in  vitro adipo-
genic differentiation. Interestingly, gene expression of the 
intermediate and late adipogenic differentiation mark-
ers FABP-4/AP2 and LPL were significantly enhanced in 
ASCs harvested by SAL compared to those from exci-
sional fat tissue (**p < 0.01) (Fig. 3b). This difference was 
seen after 7 days of adipogenic induction, but not at day 
0 before induction of differentiation in ADM. Similarly, 
gene expression of the early adipogenic marker PPAR-γ 
showed a trend toward greater expression at day 7 in cells 
derived from SAL, however this did not reach statistical 
significance (p = 0.06).
SAL and excisional fat derived ASCs equally enhance 
wound healing
To evaluate the therapeutic functionality of SAL derived 
ASCs versus ASCs isolated from excisional fat in  vivo, 
cell-seeded hydrogels [5] were applied to a previously 
established model of murine cutaneous healing [5, 24]. 
Consistent with their unimpaired in  vitro functional-
ity, ACSs obtained via SAL demonstrated comparable 
therapeutic efficacy for cutaneous regeneration versus 
cells isolated from abdominoplasty samples (Fig.  4a). 
Both ASC treatment groups displayed significantly 
improved healing kinetics as early as day three compared 
to unseeded hydrogel controls (Fig.  4b). The acceler-
ated healing rates directly resulted in significantly faster 
wound closure times in the ASCs groups (11.4 and 10.8 
vs. 13.8 days, **p < 0.01) (Fig. 4c). These data indicate that 
ASCs derived from either SAL or excision both have a 
positive effect on in vivo regeneration.
SAL and excisional fat derived ASCs both enhance wound 
vascularity
Improvement of wound healing by ASCs is widely attrib-
uted to enhanced vascularization of the wound bed [17, 
25–28]. Indeed, both ASC treatment groups showed sig-
nificantly enhanced neovascularization compared with 
acellular scaffold controls (*p  <  0.05), confirming our 
results regarding in  vivo regenerative potential (Fig.  5). 
Similar to the wound healing outcomes, no signifi-
cant differences between the two ASC groups could be 
detected. This further corroborates that in vivo regenera-
tive potential is preserved in SAL-derived ASCs.
Discussion
Despite exciting discoveries regarding the regenerative 
potential of ASCs, the use of ASCs in clinical practice 
is still in its infancy. This is in part due to an incomplete 
understanding of how various harvesting and process-
ing methods affect ASC biology. Several different meth-
ods for fat harvest exist, whether for fat grafting in the 
operating room or for the isolation of ASCs in the lab-
oratory [29–32]. With the goal of decreasing donor site 
morbidity with increased operative efficiency, new har-
vesting techniques have been developed beyond the tra-
ditional technique of resection, such as SAL, UAL, LAL, 
and power-assisted liposuction (PAL). However, while 
some of these methods may offer improvements in clini-
cal variables such as decreased operative time, improved 
skin retraction, and minimized blood loss [33], the cur-
rent body of literature regarding the comparative effects 
of these methods on preservation of the cellular con-
tents is largely incomplete and often inconsistent. These 
potential effects are of interest to translational research-
ers utilizing ASCs in regenerative therapies, as well as 
to clinicians looking to improve viability of transferred 
fat grafts. To our knowledge, there has been no study to 
date that determines the effects of SAL on proliferation, 
differentiation potential, and wound healing when com-
pared to the standard of excisional fat. We evaluate the 
characteristics of SAL and resection-derived ASCs in a 
laboratory setting with paired samples from patients who 
serve as their own controls. These controlled conditions 
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enable an exact assessment potentially superior to clini-
cal comparisons utilizing one-step cell isolation protocols 
in the operating room.
In this study, we found that ASCs obtained from both 
SAL and excised abdominoplasty tissue occurred at high 
frequencies and viability, although excised adipose tissue 
provided greater yields of ASCs when compared to SAL. 
Factors influencing ASC yield have been discussed con-
troversially in the literature. In addition to harvesting 
technique, patient demographics can affect ASC fre-
quency in adipose tissue. Generally, there are no detect-
able differences in ASC yield or proliferation with age 
Fig. 2 SAL and excisional fat derived ASCs have equal osteogenic lineage differentiation capacities. a Representative images and quantification of 
Alkaline Phosphatase and b Alizarin Red staining following osteogenic differentiation of SAL and excisional fat derived ASCs. c RT‑PCR quantifying 
the expression of early (RUNX2), and late (OCN) osteogenic markers in vitro. n = 3. All data are means ± one SEM. RUNX2 runt‑related transcription 
factor 2, OCN osteocalcin
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[19, 34]. However, high donor age and comorbidities such 
as diabetes significantly impair ASC functionality [19, 
35] and donor gender affects ASC properties, with more 
robust osteogenic differentiation in ASCs from male 
patients [36]. Furthermore, previous studies from our 
group have demonstrated depot-specific differences in 
ASCs, with ASCs isolated from the flank and thigh show-
ing greater osteogenic potential but ASCs from the flank 
having lesser adipogenic capabilities when compared to 
the arm and abdomen [37].
The capability of ASCs to differentiate down multi-
ple lineages is of critical importance in their utility in 
Fig. 3 SAL derived ASCs have similar adipogenic lineage differentiation capacities. a Representative images and quantification of Oil Red O staining 
following adipogenic differentiation of SAL and abdominoplasty derived ASCs. b RT‑PCR quantifying the expression of adipogenic markers in vitro. 
Top PPAR‑γ, middle FABP4, bottom LPL. n = 3. All data are means ± one SEM. PPAR-γ peroxisome proliferator‑activated receptor γ, FABP4 fatty acid 
binding protein 4, LPL lipoprotein lipase
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tissue engineering and cell-based regenerative therapies. 
Previous studies from our group have found no signifi-
cant difference in osteogenic differentiation potential 
between suction-assisted lipoaspiration and third-gen-
eration ultrasound-generation lipoaspiration, despite 
the mechanical disruption delivered during ultrasound 
application [17]. In contrast, ASCs derived from LAL 
have been shown to suffer from decreased osteogenic dif-
ferentiation capacity relative to those from SAL [16]. The 
results from this study demonstrate that SAL does not 
impair the osteogenic differentiation potential of ASCs. 
This is not surprising, since SAL delivers a mechanical 
effect rather than heat, and is thus an approach more 
similar to UAL than LAL.
Interestingly, we found that expression of adipogenic 
differentiation markers FABP-4 and LPL were signifi-
cantly higher in SAL derived ASCs when compared to 
those harvested from excisional abdominoplasty fat 
tissue. Expression of the early adipogenic marker PPAR-γ 
was also greater, although not significantly so. Our find-
ings corroborate those in a recent study by Keck et  al. 
[38], who determined expression of adiponectin, PPAR-γ, 
and GLUT4 to be significantly increased in ASCs from 
PAL, a technique analogous to SAL, when compared 
to manual aspiration. A potential explanation for these 
findings may be found in the cellular effects of mecha-
notransduction, the conversion of mechanical forces 
to biochemical signals [39]. It is becoming increasingly 
probable that ASCs are subject to significant mecha-
notransductive effects [40, 41], much as are other progen-
itor cell types. However, the literature is still developing 
in this area and results thus far have been inconsistent 
and largely focused on either adipocytes or adipose tissue 
as a whole [42, 43]. Due to the conflicting data regarding 
mechanotransduction in ASCs, one may turn to the BM-
MSC literature for potential clues. Importantly, shear 
Fig. 4 Application of SAL and abdominoplasty derived ASCs are equalliy efficacious to enhance cutaneous healing. a Gross appearance, b wound 
healing kinetics, and c closing times of humanized excisional murine wounds treated with hydrogel seeded hASCs harvested via SAL, abdomino‑
plasty or unseeded hydrogel. n = 8. Asterisk indicates p ≤ 0.05. All data are means ± one SEM
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stress has been previously shown to cause changes in 
cytoskeletal distribution in MSCs, ultimately leading to 
alterations in differentiation potential. Specifically, Chang 
et al. [44] found that shear stress led to increased expres-
sion of the early adipokine PPAR-γ and decreased expres-
sion of the early osteogenic gene RUNX-2 [44]. Here, we 
see similar effects in ASCs, with trends toward increased 
PPAR-γ and decreased RUNX-2 expression in ASCs 
isolated from lipoaspirates when compared to those 
obtained from excised adipose tissue. Therefore we may 
conclude that mechanical forces exerted during lipoaspi-
ration alters ASC biology, at least at the transcriptional 
level. However, further work is needed to clarify these 
potential effects.
ASCs harbor great promise for tissue regenera-
tion applications [5]. In this study we demonstrate that 
SAL-harvested ASCs have an identical potential for the 
enhancement of cutaneous healing when compared to 
ASCs derived from excisional fat. Furthermore, wounds 
treated with either ASC population displayed signifi-
cantly greater vascularity compared to an unseeded 
scaffold control group. These promising findings distin-
guish SAL as a reliable method for obtaining ASCs suit-
able and effective for regenerative medicine approaches, 
and an equivalent source of ASCs when compared to 
those derived from three-dimensionally intact adipose 
tissue.
Conclusion
ASCs represent a promising source of multipotent cells 
for tissue engineering and regenerative medicine. Suc-
tion-assisted lipoaspiration offers a possibility for rela-
tive ease of harvest of ASCs with minimal donor site 
morbidity. Here we show that SAL lipoaspirates provide 
a slightly decreased yield of viable ASCs when com-
pared to resected adipose tissue. ASCs derived from 
SAL retain full multipotency and regenerative capabili-
ties. Overall, these findings suggest that SAL is a reliable 
and effective method of obtaining ASCs for tissue engi-
neering approaches and cell-based therapies when com-
pared to the gold standard of minimally-manipulated 
excisional adipose tissue, and does not damage ASCs in 
Fig. 5 Both ASC treatment groups display enhanced cutaneous wound vascularity. CD31 staining confirmed a significant increase in neovasculari‑
zation among both ASC tretment groups. DAPI nuclear stain. Scale bar 100 μm. n = 8. Asterisk indicates p ≤ 0.05. All data are means ± one SEM
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terms of viability, osteogenic and adipogenic differen-
tiation capacity, wound regenerative potential, or wound 
neovascularization.
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